EXPLORING ENVIRONMENTAL IMPACTS OF SWITCHING SALMETEROL/FLUTICASONE PROPIONATE (SAL/FP) FROM METERED DOSE INHALER (MDI) TO DRY POWDER INHALER (DPI) IN RESPIRATORY ILLNESS IN THE UNITED KINGDOM

被引:0
|
作者
Siddiqui, A. H. [1 ]
Hughes, R. [1 ]
Brandolini, G. [1 ]
Hirst, A. [2 ]
机构
[1] Adelphi Values PROVE, Bollington, Cheshire, England
[2] Adelphi Values PROVE, Bollington, CHW, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE311
引用
收藏
页码:S114 / S114
页数:1
相关论文
共 48 条
  • [41] Dry Powder Inhalers (DPIs) vs Metered Dose Inhaler (MDI) with valved spacer: Using Functional Respiratory Imaging (FRI) to assess modelled lung deposition in a COPD patient
    Suggett, J.
    Kushnarev, V
    Sadafi, H.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [42] ASSESSING CENTRAL AND PERIPHERAL PULMONARY DEPOSITION OF THREE FLUTICASONE PROPIONATE (FP) DRY POWDER INHALER (DPI) FORMULATIONS WITH DIFFERENT AERODYNAMIC PARTICLE SIZE DISTRIBUTIONS (APSD) IN HEALTHY SUBJECTS VIA POPULATION PHARMACOKINETICS MODELING
    Drescher, Stefanie K.
    Chen, Mong-Jen
    Kurumaddali, Abhinav
    Schilling, Uta
    Jiao, Yuanyuan
    Shao, Jie
    Seay, Brandon
    Baumstein, Sandra M.
    Abu-Hasan, Mutasim N.
    Delvadia, Renishkumar
    Winner, Lawrence
    Tabulov, Christine
    Saluja, Bavna
    Shur, Jag
    Price, Robert
    Hindle, Michael
    Wei, Xiangyin
    Oguntimein, Murewa
    Conti, Denise S.
    Bulitta, Juergen
    Hochhaus, Guenther
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (02) : A10 - A10
  • [43] A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI)
    Al-Ahmad, Mona
    Webb, David
    RESPIRATORY MEDICINE, 2022, 194
  • [44] A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study
    Kupczyk, Maciej
    Majak, Pawel
    Kuna, Piotr
    Asankowicz-Bargiel, Beata
    Baranska, Eliza
    Dobek, Rafal
    Garbicz, Slawomir
    Jerzynska, Joanna
    Latos, Anna
    Machowiak, Wojciech
    Majorek-Olechowska, Bernadetta
    Olech-Cudzik, Anna
    Poziomkowska-Gesicka, Iwona
    Rulewicz-Warniello, Miroslawa
    Swiderska, Anna
    Tarnowski, Michal
    Kopyto, Przemyslaw
    RESPIRATORY MEDICINE, 2021, 176
  • [45] CONSISTENCY OF DOSE DELIVERY OF FLUTICASONE FUROATE (FF)/UMECLIDINIUM (UMEC)/VILANTEROL (VI) ACROSS PATIENT RELEVANT INHALATION FLOW RATES FROM A DRY-POWDER INHALER (DPI)
    Prime, David
    Hamilton, Melanie
    Patmore, Oonagh
    CHEST, 2019, 156 (04) : 1786A - 1786A
  • [46] Exploring the impact of extrinsic lactose fines, a USP modified sampling device and modified centrifuge tube on the delivered dose uniformity and drug detachment performance of a fluticasone propionate dry powder inhaler
    Mehta, Piyush P.
    Kadam, Shivajirao S.
    Pawar, Atmaram P.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 57
  • [47] Metered Dose Inhaler (MDI) with Valved Holding Chamber (VHC) vs Dry Powder Inhalers (DPIs): Using Functional Respiratory Imaging (FRI) to Assess Modelled Lung Deposition in an Asthmatic Patient
    Suggett, J.
    Kushnarev, V.
    Van Holsbeke, C.
    Van Steen, S.
    Mignot, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [48] Effectiveness and Safety of AVESSA™, (Fixed Dose Combination of Formoterol 6 mcg and Fluticasone Propionate 250 mcg) Dry Powder Inhaler (DPI), in Management of "Partly Controlled & Uncontrolled" Asthma - A Real World Study in India.
    Shammem, M.
    Kacker, R.
    Singh, B. P.
    Arora, S.
    Rajput, A. K.
    Munshi, V. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179